25 related articles for article (PubMed ID: 12810253)
1. Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system.
Murase T; Inagaki A; Masaki A; Fujii K; Narita T; Ri M; Hanamura I; Iida S; Inagaki H
J Clin Exp Hematop; 2019 Sep; 59(3):135-139. PubMed ID: 31391406
[TBL] [Abstract][Full Text] [Related]
2. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.
Walker BA; Wardell CP; Murison A; Boyle EM; Begum DB; Dahir NM; Proszek PZ; Melchor L; Pawlyn C; Kaiser MF; Johnson DC; Qiang YW; Jones JR; Cairns DA; Gregory WM; Owen RG; Cook G; Drayson MT; Jackson GH; Davies FE; Morgan GJ
Nat Commun; 2015 Apr; 6():6997. PubMed ID: 25904160
[TBL] [Abstract][Full Text] [Related]
3. Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.
Arendt BK; Ramirez-Alvarado M; Sikkink LA; Keats JJ; Ahmann GJ; Dispenzieri A; Fonseca R; Ketterling RP; Knudson RA; Mulvihill EM; Tschumper RC; Wu X; Zeldenrust SR; Jelinek DF
Blood; 2008 Sep; 112(5):1931-41. PubMed ID: 18567838
[TBL] [Abstract][Full Text] [Related]
4. Complex rearrangements involving der(8)t(8;20) and der(14)t(8;14)t(11;14), CCND1, and duplication of IgH constant region in acute plasmablastic leukemia.
Knutsen T; Vakulchuk A; Mosijczuk AD; Gabrea A; Ried T; Tretyak N
Cancer Genet Cytogenet; 2006 Jan; 164(2):137-41. PubMed ID: 16434317
[TBL] [Abstract][Full Text] [Related]
5. Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
Nakazawa N; Nishida K; Tamura A; Kobayashi M; Iwai T; Horiike S; Nishigaki H; Otsuki T; Tomiyama Y; Fujii H; Kashima K; Taniwaki M
Cancer Genet Cytogenet; 2000 Mar; 117(2):89-96. PubMed ID: 10704676
[TBL] [Abstract][Full Text] [Related]
6. A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.
Kalff A; Khong T; Wall M; Gorniak M; Mithraprabhu S; Campbell LJ; Spencer A
Haematologica; 2015 Feb; 100(2):e60-2. PubMed ID: 25381133
[No Abstract] [Full Text] [Related]
7. Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele.
Nishio Y; Sakai H; Saiki Y; Uchida A; Uemura Y; Matsunawa M; Isobe Y; Kato M; Tomita N; Miura I
Int J Hematol; 2019 May; 109(5):572-577. PubMed ID: 30887274
[TBL] [Abstract][Full Text] [Related]
8. A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH gene.
Ohbayashi K; Taniwaki M; Ninomiya M; Kiyoi H; Iida S; Ueda R; Naoe T
Cancer Genet Cytogenet; 2003 Jul; 144(1):31-5. PubMed ID: 12810253
[TBL] [Abstract][Full Text] [Related]
9. Primary Plasma Cell Leukemia Associated with t(6;14)(p21;q32) and IGH Rearrangement: A Case Study and Review of the Literature.
Cho SY; Lim G; Oh SH; Lee HJ; Suh JT; Lee J; Lee WI; Lee HG; Yoon HJ; Park TS
Ann Clin Lab Sci; 2011; 41(3):277-81. PubMed ID: 22075513
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
[TBL] [Abstract][Full Text] [Related]
11. Non-random chromosomal rearrangements and their implications in clinical features and outcome of multiple myeloma and plasma cell leukemia.
Taniwaki M; Nishida K; Ueda Y; Takashima T
Leuk Lymphoma; 1996 Mar; 21(1-2):25-30. PubMed ID: 8907265
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
